Method for regulating and controlling GLP-1/GLP-1R and drug

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11938172
APP PUB NO 20200206324A1
SERIAL NO

16624170

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses the use of plasminogen to regulate GLP-1/GLP-1R and treat a GLP-1/GLP-1R-related condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TALENGEN INTERNATIONAL LIMITEDSUITE 2409 EVERBRIGHT CENTRE 108 GLOUCESTER ROAD WANCHAI HONG KONG 999077 999077

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Jinan Guangdong, CN 55 231

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 26, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 26, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 26, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00